Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Leukemia drug holiday: study tests if patients can pause treatment

NCT ID NCT04626024

First seen Jan 06, 2026 · Last updated May 22, 2026 · Updated 17 times

Summary

This study looks at whether people with chronic myeloid leukemia (CML) who have had a very low level of cancer for at least two years can safely stop taking their daily targeted therapy (TKI). Seventeen adults who have been on TKI for over three years will stop their medication and be monitored closely for relapse. The goal is to see if a treatment pause is possible without the cancer coming back.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC MYELOID LEUKEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Baylor College of Medicine- McNair Campus

    Houston, Texas, 77030, United States

  • Ben Taub General Hospital

    Houston, Texas, 77030, United States

  • CHI St. Luke's Health Baylor College of Medicine Medical Center

    Houston, Texas, 77030, United States

  • Harris Health System- Smith Clinic

    Houston, Texas, 77054, United States

Conditions

Explore the condition pages connected to this study.